4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-030837
Senior VP, Chief Legal Officer sold 13,741 shares at $6.23 ($85,606)
- Senior VP, Chief Legal Officer acquired 13,741 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Barnes Alane P · Senior VP, Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-04 | Exercise or conversion : show line 1 in the form | +13,741 | $4.15 | $57,025 | 121,802 | D |
| 2020-12-04 | Sale : show line 2 in the form | −13,741 | $6.23 | $85,606 | 108,061 | D |
| Open-market sales · 13,741 sh · avg $6.23 · $85,606 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-04 | Exercise or conversion : show line 3 in the form Emp. Stock Option (Right to Buy) | −13,741 | 13,741 | D |
Loading xslF345X03/form4.xml…